Last reviewed · How we verify

NCT04356521

Lateral Sagittal vs Costoclavicular Approach for Ultrasound-Guided Infraclavicular Block

Completed NA Last updated 26 October 2020
What this trial tests

NA trial testing Lateral Sagittal Approach in Anesthesia, Local in 109 participants. Completed in 20 October 2020.

Timeline
1 May 2020
Primary endpoint
1 October 2020
20 October 2020

Quick facts

Lead sponsorOndokuz Mayıs University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment109
Start date1 May 2020
Primary completion1 October 2020
Estimated completion20 October 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ondokuz Mayıs University

Who can join

Adults 18 to 65, any sex, with Anesthesia, Local or Nerve Block. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

An ultrasound-guided infraclavicular block performed with the costoclavicular (CC) approach and the lateral sagittal (LS) approach will be compared in patients scheduled for forearm and hand surgery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Lateral Sagittal Versus Costoclavicular Approaches for Ultrasound-Guided Infraclavicular Brachial Plexus Block: A Comparison of Block Dynamics Through A Randomized Clinical Trial.
    Dost B, Kaya C, Ustun YB, Turunc E, et al · · 2021 · cited 8× · PMID 33912361 · DOI 10.7759/cureus.14129

Verify or expand the search:

Other recruiting trials for Anesthesia, Local

Currently open trials in the same condition.

Other Ondokuz Mayıs University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04356521.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing